Trials / Unknown
UnknownNCT02590055
Phase 2 Study of Gemcitabine and Docetaxel Combination Chemotherapy in Patients With Carcinoma of Unknown Primary
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 29 (estimated)
- Sponsor
- Samsung Medical Center · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
It's a phase 2, single arm study of gemcitabine an docetaxel combination in patients with carcinoma of unknown primary.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | gemcitabine/docetaxel combination |
Timeline
- Start date
- 2015-10-01
- Primary completion
- 2018-09-01
- Completion
- 2019-09-01
- First posted
- 2015-10-28
- Last updated
- 2015-10-28
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02590055. Inclusion in this directory is not an endorsement.